Price $6.71 |
Market Cap
784.4M
|
Sector Consumer Non-Cyclical |
Div. Growth
-
|
|
P/E
-
|
P/B
0.74
|
P/S
0.97
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
3.1
|
Op. Cash Flow
255.7K
|
FCF
2.1
|
|
Op. Margin
17.90%
|
Net Margin
-4.30%
|
ROE
-3.80%
|
ROI
8.20%
|
|
ROA
-1.70%
|
EPS Growth
-276.00%
|
Current Ratio
2.4
|
Debt/Equity
67.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| BIQI International Holdings Co (BIQI) | $0.73 | - | - | 7.5M | Strong Buy |
| PURE Bioscience (PURE) | $0.42 | - | - | 31.9M | Strong Buy |
| ProPhase Labs Inc (PRPH) | $3.00 | - | - | 34.2M | Strong Buy |
| Prestige Consumer Healthcare I (PBH) | $30.41 | - | - | 1.5B | Strong Buy |
| MYOS RENS Technology Inc (MYOS) | $1.33 | - | - | 11.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
